TOWARD ULTRA-LONG-TERM INTRA-ARTICULAR DELIVERY OF DISEASE-MODIFYING BIOLOGICS TO REDUCE THE PROGRESSION OF POSTTRAUMATIC OSTEOARTHRITIS.
$466,970FY2025Defense Health AgencyDOD
Brigham & Womens Hospital Inc
Investigators
View source on USAspending →TOWARD ULTRA-LONG-TERM INTRA-ARTICULAR DELIVERY OF DISEASE-MODIFYING BIOLOGICS TO REDUCE THE PROGRESSION OF POSTTRAUMATIC OSTEOARTHRITIS. · GrantIndex